Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

被引：22
|
作者：
Walter, Eva [1 ]
Schmitt, Thomas [1 ]
Dietrich, Sascha [1 ]
Ho, Anthony [1 ]
Witzens-Harig, Mathias [1 ]
机构：
[1] Univ Heidelberg, Dept Internal Med 5, D-69120 Heidelberg, Germany
来源：
LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 11期
关键词：
NON-HODGKINS-LYMPHOMA; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; PLUS RITUXIMAB; PHASE-II; MULTICENTER; OLDER; CHOP;
D O I：
10.3109/10428194.2012.682311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2290 / 2292
页数：3
相关论文
共 50 条
  • [1] Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
    Micallef, Ivana N. M.
    Maurer, Matthew J.
    Wiseman, Gregory A.
    Nikcevich, Daniel A.
    Kurtin, Paul J.
    Cannon, Michael W.
    Perez, Domingo G.
    Soori, Gamini S.
    Link, Brian K.
    Habermann, Thomas M.
    Witzig, Thomas E.
    BLOOD, 2011, 118 (15) : 4053 - 4061
  • [2] Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
    Candelaria, Myrna
    Duenas-Gonzalez, Alfonso
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [3] Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma
    Roschewski, Mark
    Dunleavy, Kieron
    Wilson, Wyndham H.
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2428 - 2437
  • [4] Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
    Vitolo, Umberto
    Trneny, Marek
    Belada, David
    Burke, John M.
    Carella, Angelo Michele
    Chua, Neil
    Abrisqueta, Pau
    Demeter, Judit
    Flinn, Ian
    Hong, Xiaonan
    Kim, Won Seog
    Pinto, Antonio
    Shi, Yuan-Kai
    Tatsumi, Yoichi
    Oestergaard, Mikkel Z.
    Wenger, Michael
    Fingerle-Rowson, Gunter
    Catalani, Olivier
    Nielsen, Tina
    Martelli, Maurizio
    Sehn, Laurie H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3529 - +
  • [5] Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone
    Hui, David
    Proctor, Bradley
    Donaldson, Jane
    Shenkier, Tamara
    Hoskins, Paul
    Klasa, Richard
    Savage, Kerry
    Chhanabhai, Mukesh
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1658 - 1667
  • [6] Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
    Go, Se-Il
    Park, Mi Jung
    Song, Haa-Na
    Kim, Hoon-Gu
    Kang, Myoung Hee
    Lee, Hyang Rae
    Kim, Yire
    Kim, Rock Bum
    Lee, Soon Il
    Lee, Gyeong-Won
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (05) : 567 - 576
  • [7] Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care
    Vassilakopoulos, Theodoros P.
    Pangalis, Gerassimos A.
    Katsigiannis, Andreas
    Papageorgiou, Sotirios G.
    Constantinou, Nikos
    Terpos, Evangelos
    Zorbala, Alexandra
    Vrakidou, Effimia
    Repoussis, Panagiotis
    Poziopoulos, Christos
    Galani, Zacharoula
    Dimopoulou, Maria N.
    Kokoris, Stella I.
    Sachanas, Sotirios
    Kalpadakis, Christina
    Dimitriadou, Evagelia M.
    Siakantaris, Marina P.
    Kyrtsonis, Marie-Christine
    Dervenoulas, John
    Dimopoulos, Meletios A.
    Meletis, John
    Roussou, Paraskevi
    Panayiotidis, Panayiotis
    Beris, Photis
    Angelopoulou, Maria K.
    ONCOLOGIST, 2012, 17 (02): : 239 - 249
  • [8] Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older
    Meguro, Akiko
    Ozaki, Katsutoshi
    Sato, Kazuya
    Oh, Iekuni
    Fujiwara, Shinichiro
    Hosonuma, Rie
    Sasazaki, Miyuki
    Kikuchi, Yuji
    Hirata, Yuji
    Yamamoto, Chihiro
    Uesawa, Mitsuyo
    Kobayashi, Hiroyuki
    Matsu, Haruko
    Okabe, Hiroshi
    Uehara, Eisuke
    Nishikawa, Akinori
    Tatara, Raine
    Hatano, Kaoru
    Yamamoto, Chizuru
    Matsuyama, Tomohiro
    Toshima, Masaki
    Ueda, Masuzu
    Ohmine, Ken
    Suzuki, Takahiro
    Mori, Masaki
    Nagai, Tadashi
    Muroi, Kazuo
    Ozawa, Keiya
    LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 43 - 49
  • [9] Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy
    Huntington, Scott F.
    Talbott, Mahsa S.
    Greer, John P.
    Morgan, David S.
    Reddy, Nishitha
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1461 - 1468
  • [10] Rituximab and chemotherapy in diffuse large B-cell lymphoma
    Sonet, Anne
    Bosly, Andre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 719 - 726
12345